BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 11524033)

  • 1. Harnessing the clinical potential of antiepileptic drug therapy: dosage optimisation.
    Perucca E; Dulac O; Shorvon S; Tomson T
    CNS Drugs; 2001; 15(8):609-21. PubMed ID: 11524033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AntiEpileptic drug Monitoring in PREgnancy (EMPiRE): a double-blind randomised trial on effectiveness and acceptability of monitoring strategies.
    Thangaratinam S; Marlin N; Newton S; Weckesser A; Bagary M; Greenhill L; Rikunenko R; D'Amico M; Rogozińska E; Kelso A; Hard K; Coleman J; Moss N; Roberts T; Middleton L; Dodds J; Pullen A; Eldridge S; Pirie A; Denny E; McCorry D; Khan KS
    Health Technol Assess; 2018 May; 22(23):1-152. PubMed ID: 29737274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic variability of newer antiepileptic drugs: when is monitoring needed?
    Johannessen SI; Tomson T
    Clin Pharmacokinet; 2006; 45(11):1061-75. PubMed ID: 17048972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic monitoring of antiepileptic drugs during pregnancy and in the postpartum period: is it useful?
    Adab N
    CNS Drugs; 2006; 20(10):791-800. PubMed ID: 16999450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic optimisation of anticonvulsant therapy.
    Thomson AH; Brodie MJ
    Clin Pharmacokinet; 1992 Sep; 23(3):216-30. PubMed ID: 1511537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levetiracetam Clinical Pharmacokinetic Monitoring in Pediatric Patients with Epilepsy.
    Tan J; Paquette V; Levine M; Ensom MHH
    Clin Pharmacokinet; 2017 Nov; 56(11):1267-1285. PubMed ID: 28353057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic monitoring of antiepileptic drugs for epilepsy.
    Tomson T; Dahl ML; Kimland E
    Cochrane Database Syst Rev; 2007 Jan; 2007(1):CD002216. PubMed ID: 17253477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The management of epilepsy in the 1990s. Acquisitions, uncertainties and priorities for future research.
    Beghi E; Perucca E
    Drugs; 1995 May; 49(5):680-94. PubMed ID: 7601010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lacosamide therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs.
    Contin M; Albani F; Riva R; Candela C; Mohamed S; Baruzzi A
    Ther Drug Monit; 2013 Dec; 35(6):849-52. PubMed ID: 23942540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic and pharmacodynamic interactions of valproate, phenytoin, phenobarbitone and carbamazepine with curcumin in experimental models of epilepsy in rats.
    Reeta KH; Mehla J; Pahuja M; Gupta YK
    Pharmacol Biochem Behav; 2011 Sep; 99(3):399-407. PubMed ID: 21641922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lacosamide serum concentrations in adult patients with epilepsy: the influence of gender, age, dose, and concomitant antiepileptic drugs.
    Markoula S; Teotonio R; Ratnaraj N; Duncan JS; Sander JW; Patsalos PN
    Ther Drug Monit; 2014 Aug; 36(4):494-8. PubMed ID: 24562047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacodynamic interactions of antiepileptic drugs: From bench to clinical practice.
    Verrotti A; Lattanzi S; Brigo F; Zaccara G
    Epilepsy Behav; 2020 Mar; 104(Pt A):106939. PubMed ID: 32058303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimisation of antiepileptic drug therapy. The importance of serum drug concentration monitoring.
    Yukawa E
    Clin Pharmacokinet; 1996 Aug; 31(2):120-30. PubMed ID: 8853934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiepileptic drug therapy.
    Podell M
    Clin Tech Small Anim Pract; 1998 Aug; 13(3):185-92. PubMed ID: 9775509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies to prevent overtreatment with antiepileptic drugs in patients with epilepsy.
    Schmidt D
    Epilepsy Res; 2002 Nov; 52(1):61-9. PubMed ID: 12445961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current issues in the treatment of epilepsy.
    Pugh CB; Garnett WR
    Clin Pharm; 1991 May; 10(5):335-58. PubMed ID: 2049897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiepileptic Drugs.
    Abou-Khalil BW
    Continuum (Minneap Minn); 2016 Feb; 22(1 Epilepsy):132-56. PubMed ID: 26844734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug treatment of epilepsy in elderly people: focus on valproic Acid.
    Stephen LJ
    Drugs Aging; 2003; 20(2):141-52. PubMed ID: 12534314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overtreatment in epilepsy: how it occurs and how it can be avoided.
    Perucca E; Kwan P
    CNS Drugs; 2005; 19(11):897-908. PubMed ID: 16268662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Updated Overview on Therapeutic Drug Monitoring of Recent Antiepileptic Drugs.
    Jacob S; Nair AB
    Drugs R D; 2016 Dec; 16(4):303-316. PubMed ID: 27766590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.